@article{sandie2022ni,
  title   = {Non-inferiority test for a continuous variable with a flexible margin in an active controlled trial: an application to the {Stratall ANRS 12110 / ESTHER} trial},
  author  = {Sandie, A. and others},
  journal = {Trials},
  year    = {2022},
  volume  = {23},
  pages   = {202}
}

@article{cuzick2022interpreting,
  title   = {Interpreting the results of noninferiority trials — a review},
  author  = {Cuzick, J. and Sasieni, P.},
  journal = {British Journal of Cancer},
  year    = {2022},
  volume  = {127},
  pages   = {1755--1759}
}

@report{fda2016ni,
  title        = {Non-Inferiority Clinical Trials to Establish Effectiveness: Guidance for Industry},
  author       = {{U.S. Food and Drug Administration}},
  institution  = {U.S. Department of Health and Human Services},
  year         = {2016},
  address      = {Silver Spring, MD, USA}
}

@article{werk2008paclitaxel,
  title   = {Inhibition of restenosis in femoropopliteal arteries: paclitaxel-coated versus uncoated balloon — the Femoral Paclitaxel Randomized Pilot Trial},
  author  = {Werk, M. and others},
  journal = {Circulation},
  year    = {2008},
  volume  = {118},
  pages   = {1358--1365}
}

@article{tepe2008local,
  title   = {Local delivery of paclitaxel to inhibit restenosis during angioplasty of the leg},
  author  = {Tepe, G. and others},
  journal = {The New England Journal of Medicine},
  year    = {2008},
  volume  = {358},
  pages   = {689--699}
}

@article{rocha2007performance,
  title   = {Performance goals and endpoint assessments for clinical trials of femoropopliteal bare nitinol stents in patients with symptomatic peripheral arterial disease},
  author  = {Rocha-Singh, K. J. and others},
  journal = {Catheterization and Cardiovascular Interventions},
  year    = {2007},
  volume  = {69},
  pages   = {910--919}
}
